Skip to Main Content

Paper Details

FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer.
Urol Oncol
12
2018
Author NameAffiliation
Holger S??ltmannNational Center for Tumor Diseases (NCT), German Cancer Research Center
Esther HerpelInstitute of Pathology, University of Heidelberg School of Medicine, Germany Tissue Bank of the National Center for Tumor Diseases (NCT)
Nora M NavoneUniversity of Texas, MD Anderson Cancer Center
  • 1 - 3

Datasets